Society of Hematologic Oncology

Free SOHO Membership: www.sohoonline.org

 

Impact of Comorbidities in Treatment Choice of CML: TKI Toxicities Need to Be Considered, Frontline Therapy Switching/Stopping Depends on Comorbidites, Vascular Risk Major Consideration

104 views
November 18, 2019
Comments 0
Login to view comments. Click here to Login